Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin T Matulay

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Urology|June 19, 2016
Author ReplyWilson Sui, Marissa C Theofanides, Justin T Matulay, et al.
Urology|May 8, 2016
Utilization of Preoperative Laboratory Testing for Low-risk, Ambulatory Urologic ProceduresWilson Sui, Marissa C Theofanides, Justin T Matulay, et al.
Urology|February 7, 2017
Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin TherapyDennis J Robins, Wilson Sui, Justin T Matulay, et al.
The Canadian Journal of Urology|August 22, 2016
Perioperative blood transfusion predicts short term morbidity after nephrectomyWilson Sui, Ifeanyi C Onyeji, Justin T Matulay, et al.
Urologic Oncology|November 12, 2025
Protocol-driven same day discharge for robotic radical prostatectomyEmily H Roebuck, Lila G McGrath, Myra Robinson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2016
Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program databaseWilson Sui, Ifeanyi C Onyeji, Justin T Matulay, et al.
Urologic Oncology|February 2, 2019
The impact of squamous histology on survival in patients with muscle-invasive bladder cancerJustin T Matulay, Solomon L Woldu, Amy Lim, et al.
Urologic Oncology|June 9, 2023
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sitesEarle F Burgess, Chad A Livasy, James T Symanowski, et al.
Urology|February 12, 2015
Serum cystatin C as a novel marker to differentiate pseudoazotemia in the setting of intraperitoneal urine extravasationSolomon L Woldu, Justin T Matulay, Mark V Silva, et al.
Clinical Genitourinary Cancer|November 9, 2017
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active SurveillanceMichael J Whalen, Jamie S Pak, Danny Lascano, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Urology|June 19, 2016
Author ReplyWilson Sui, Marissa C Theofanides, Justin T Matulay, et al.
Urology|May 8, 2016
Utilization of Preoperative Laboratory Testing for Low-risk, Ambulatory Urologic ProceduresWilson Sui, Marissa C Theofanides, Justin T Matulay, et al.
Urology|February 7, 2017
Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin TherapyDennis J Robins, Wilson Sui, Justin T Matulay, et al.
The Canadian Journal of Urology|August 22, 2016
Perioperative blood transfusion predicts short term morbidity after nephrectomyWilson Sui, Ifeanyi C Onyeji, Justin T Matulay, et al.
Urologic Oncology|November 12, 2025
Protocol-driven same day discharge for robotic radical prostatectomyEmily H Roebuck, Lila G McGrath, Myra Robinson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2016
Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program databaseWilson Sui, Ifeanyi C Onyeji, Justin T Matulay, et al.
Urologic Oncology|February 2, 2019
The impact of squamous histology on survival in patients with muscle-invasive bladder cancerJustin T Matulay, Solomon L Woldu, Amy Lim, et al.
Urologic Oncology|June 9, 2023
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sitesEarle F Burgess, Chad A Livasy, James T Symanowski, et al.
Urology|February 12, 2015
Serum cystatin C as a novel marker to differentiate pseudoazotemia in the setting of intraperitoneal urine extravasationSolomon L Woldu, Justin T Matulay, Mark V Silva, et al.
Clinical Genitourinary Cancer|November 9, 2017
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active SurveillanceMichael J Whalen, Jamie S Pak, Danny Lascano, et al.
Pageof 5